Toxic hepatocellular hepatitis due to labetalol;Hepatitis tóxica hepatocelular por labetalol

Gastroenterologia y Hepatologia

Volumn 38, Issue 5, 2015, Pages 326-327

  Castiella, Agustin ^a   Iglesias, Utsune ^a   Zapata, Eva ^a   Zubiaurre, Leire ^a   Iribarren, Arantxa ^a  

^a HOSPITAL DE MENDARO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;

HUMAN; LETTER; LIVER TOXICITY; TOXIC HEPATITIS; ADULT; ASYMPTOMATIC DISEASE; BLOOD; CASE REPORT; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; PRE-ECLAMPSIA; PREGNANCY;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADULT; ASYMPTOMATIC DISEASES; CHEMICAL AND DRUG INDUCED LIVER INJURY; FEMALE; HUMANS; LABETALOL; PRE-ECLAMPSIA; PREGNANCY;

EID: 84927978523     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2014.06.004     Document Type: Letter

References (10)

1. National High Blood Pressure Education Program. Working Group on High Blood Pressure in Pregnancy. Working group report on high blood pressure in pregnancy. Bethesda, Md.: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institutes, 2000; NIH publication n.° 00-3029.
2. Stumpf J.L. Fatal hepatotoxicity induced by hydralazine or labetalol. Pharmacotherapy 1991, 11:415-418.
3. Danan G., Benichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries. J Clin Epidemiol 1993, 46:1323-1330.
4. Álvarez F., Berg P.A., Bianchi F.B., Bianchi L., Burroughs A.K., Cancado E.L., et al. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatology 1999, 31:929-938.
5. Clark J.A., Zimmerman H.J., Tanner L.A. Labetalol hepatotoxicity. Ann Intern Med 1990, 113:210-213.
6. Lucena M.I., Kaplowitz N., Hallal H., Castiella A., García-Bengoechea M., Otazua P., et al. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis. J Hepatol 2011, 55:820-827.
7. Ohmoto K., Yamamoto S. Drug induced liver injury associated with antinuclear antibodies. Scand J Gastroenterol 2002, 134:5-6.
8. Hinrichsen H., Lütttges J., Klöppel G., Fölsch U.R., Schmidt W.E. Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially. Scand J Gastroenterol 2001, 36:780-783.
9. Lee W.M. Drug induced hepatotoxicity. N Engl J Med 2003, 349:474-485.
10. Navarro V.J., Senior J.R. Drug-related hepatotoxicity. N Engl J Med 2006, 354:731-739.